Vik Chopra Analyst PerformanceMedTech Equity Research Analyst at Wells Fargo & CompanyVik Chopra is a stock analyst at Wells Fargo & Company in the medical sector, covering 15 publicly traded companies. Over the past year, Vik Chopra has issued 45 stock ratings, including strong buy, buy, and hold recommendations. While full access to Vik Chopra's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Vik Chopra's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings55 Last 1 YearsBuy Recommendations50.91% 28 Buy RatingsCompanies Covered15 Unique Companies Ratings Distribution55RatingsDistribution of strong buy, buy, hold, and sell ratings by Vik Chopra.RatingPercentageCount Strong Buy9.1%5 ratings Buy41.8%23 ratings Hold49.1%27 ratings Sell0.0%0 ratingsOut of 55 total stock ratings issued by Vik Chopra at Wells Fargo & Company, the majority (49.1%) have been Hold recommendations, followed by 41.8% Buy and 9.1% Strong Buy.Best & Worst CallsBest Call000.0%MASIMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%ALGNFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ53.3% of companies on NASDAQ8 companiesNYSE46.7% of companies on NYSE7 companiesVik Chopra, an analyst at Wells Fargo & Company, currently covers 15 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical15 companies100.0%Vik Chopra of Wells Fargo & Company specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED INSTRUMENTS7 companies46.7%MED/DENTAL - SUPP4 companies26.7%MED PRODUCTS2 companies13.3%MEDICAL INFO SYS1 company6.7%MEDICAL SERVICES1 company6.7% Vik Chopra's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsISRGIntuitive Surgical7/20/2026Reiterated Rating$347.10Outperform$0.0000.00% ROINVSTEnvista7/8/2026Initiated Coverage$25.77$27.00Market Perform$0.0000.00% ROIIARTIntegra LifeSciences7/8/2026Initiated Coverage$17.30$19.00Market Perform$0.0000.00% ROIATECAlphatec7/8/2026Initiated Coverage$9.21$11.00Outperform$0.0000.00% ROITFXTeleflex7/8/2026Initiated Coverage$130.17$159.00Outperform$0.0000.00% ROIZBHZimmer Biomet7/8/2026Initiated Coverage$87.65$95.00Market Perform$0.0000.00% ROIISRGIntuitive Surgical7/8/2026Initiated Coverage$415.10$518.00Outperform$0.0000.00% ROIALGNAlign Technology7/8/2026Initiated Coverage$174.68$209.00Outperform$0.0000.00% ROIENOVEnovis7/8/2026Initiated Coverage$23.64$29.00Outperform$0.0000.00% ROIALGNAlign Technology7/8/2026Upgrade$178.17Strong-Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ATECAlphatec7/8/2026Upgrade$9.51Strong-Buy$0.0000.00% ROIENOVEnovis7/8/2026Upgrade$25.17Strong-Buy$0.0000.00% ROIHSICHenry Schein7/8/2026Upgrade$83.86Hold$0.0000.00% ROIIARTIntegra LifeSciences7/8/2026Upgrade$18.39Hold$0.0000.00% ROIISRGIntuitive Surgical7/8/2026Upgrade$411.55Strong-Buy$0.0000.00% ROINVSTEnvista7/8/2026Upgrade$25.75Hold$0.0000.00% ROITFXTeleflex7/8/2026Upgrade$134.16Strong-Buy$0.0000.00% ROIZBHZimmer Biomet7/8/2026Upgrade$89.24Hold$0.0000.00% ROISOLVSolventum2/27/2026Lower Price Target$74.14$83.00Equal Weight$0.0000.00% ROIIARTIntegra LifeSciences2/27/2026Lower Price Target$11.31$12.00Equal Weight$0.0000.00% ROIXRAYDENTSPLY SIRONA2/27/2026Boost Price Target$14.42$13.00Equal Weight$0.0000.00% ROIGMEDGlobus Medical2/26/2026Boost Price Target$96.31$104.00Overweight$0.0000.00% ROIHSICHenry Schein2/25/2026Boost Price Target$82.51$87.00Equal Weight$0.0000.00% ROIMASIMasimo2/18/2026Downgrade$174.96$180.00Equal Weight$0.0000.00% ROINVSTEnvista2/6/2026Boost Price Target$28.23$26.00Equal Weight$0.0000.00% ROIALGNAlign Technology2/5/2026Boost Price Target$161.30$200.00Overweight$0.0000.00% ROICNMDCONMED1/29/2026Boost Price Target$38.59$42.00Equal Weight$0.0000.00% ROIMASIMasimo12/5/2025Reiterated Rating$142.26$190.00Overweight$0.0000.00% ROIGMEDGlobus Medical11/7/2025Boost Price Target$83.43$79.00Overweight$0.0000.00% ROIENOVEnovis11/7/2025Boost Price Target$28.38$42.00Overweight$0.0000.00% ROIXRAYDENTSPLY SIRONA11/7/2025Lower Price Target$11.16$12.00Equal Weight$0.0000.00% ROICNMDCONMED11/6/2025Lower Price Target$42.67$47.00Equal Weight$0.0000.00% ROINPCENeuroPace11/5/2025Boost Price Target$12.54$16.00Overweight$0.0000.00% ROIMASIMasimo11/5/2025Lower Price Target$140.88$187.00Overweight$0.0000.00% ROIHSICHenry Schein11/5/2025Boost Price Target$71.58$76.00Equal Weight$0.0000.00% ROIALGNAlign Technology10/30/2025Lower Price Target$141.34$181.00Overweight$0.0000.00% ROIATECAlphatec10/16/2025Boost Price Target$13.99$16.00Overweight$0.0000.00% ROISOLVSolventum9/15/2025Boost Price Target$73.00$82.00Equal Weight$0.0000.00% ROINPCENeuroPace8/13/2025Lower Price Target$9.13$15.00Overweight$0.0000.00% ROIGMEDGlobus Medical8/8/2025Lower Price Target$56.92$66.00Overweight$0.0000.00% ROIALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.See the 5 stocks to avoidENOVEnovis8/8/2025Lower Price Target$28.26$41.00Overweight$0.0000.00% ROISOLVSolventum8/8/2025Boost Price Target$73.26$79.00Equal Weight$0.0000.00% ROIXRAYDENTSPLY SIRONA8/8/2025Lower Price Target$12.79$15.00Equal Weight$0.0000.00% ROINVSTEnvista8/1/2025Boost Price Target$20.53$19.00Equal Weight$0.0000.00% ROIALGNAlign Technology7/31/2025Lower Price Target$132.69$199.00Overweight$0.0000.00% ROIMASIMasimo5/7/2025Lower Price Target$149.23$190.00Overweight$000.0000.00% ROIIARTIntegra LifeSciences5/6/2025Lower Price Target$13.27$13.00Equal Weight$00.0000.00% ROICNMDCONMED5/1/2025Lower Price Target$56.93$57.00Equal Weight$00.0000.00% ROISOLVSolventum2/28/2025Boost Price Target$79.28$75.00Equal Weight$00.0000.00% ROIMASIMasimo2/26/2025Boost Price Target$169.54$205.00Overweight$000.0000.00% ROIGMEDGlobus Medical2/21/2025Lower Price Target$82.74$93.00Overweight$00.0000.00% ROIALGNAlign Technology2/14/2025Initiated Coverage$204.89$255.00Overweight$000.0000.00% ROIXRAYDENTSPLY SIRONA2/14/2025Initiated Coverage$18.77$20.00Equal Weight$00.0000.00% ROIHSICHenry Schein2/14/2025Initiated Coverage$77.62$80.00Equal Weight$00.0000.00% ROICNMDCONMED2/6/2025Lower Price Target$70.96$70.00Equal Weight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsDeutsche Bank AktiengesellschaftStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
